The invention is a series of synthetic virus-like particles comprising a heterologous
conformational epitope useful in the characterization of human papillomavirus infection,
and useful to vaccinate individual for protection against HPV 6 and HPV 11 infections,
and assays employing the synthetic virus-like particles.